Home Lykos Therapeutics

Lykos Therapeutics

In operation
Series A
Commercial Developer of Prescription Psychedelics
Basic
Enterprise Profile

Basic Information

MAPS PBC Focuses on Developing and Commercializing Prescription Psychedelics to Bring Better Treatment to Those Suffering from Mental Illnesses. MAPS PBC, Established in 2014, is a Subsidiary of the 501(c)(3) Non-Profit Organization, the Multidisciplinary Association for Psychedelic Studies.
Lykos Therapeutics
California,United States of America
101~500 people
January 01, 2014
askmaps@maps.org

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Department of Psychiatry Mental Disorders Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs